Abstract:Objective To investigate the effect of low-frequency ultrasound on the release of vancomycin from antibiotic-loaded bone cement (ALBC) and its regularity in vitro and in vivo. Methods ALBC specimens were successfully manufactured for in vitro and in vivo assays. 5% and 10% ALBC specimens were both randomly divided into three groups: the control group, 100 mW/cm2 ultrasound group and 300 mW/cm2 ultrasound group. After immersing in PBS of 40 ml for 8 h, the four ultrasound groups were exposed to a timed local ultrasonic field for 30 min, then the drug cumulative concentrations were observed during a 2.5 h period after exposure and on the 24th hour after immersion. Sixteen healthy New Zealand white rabbits were divided randomly into two groups: the ultrasound group was exposed to a local timed intermittent ultrasound field and the control group not. Samples of drainage fluid and urine were collected at programmed intervals during a 5 d period, and the ALBC specimens were extracted from rabbits four weeks after implantations with all their concentrations measured by fluorescence polarization immunoassay (FPIA). Results After immersing 24 h in vitro, the cumulative concentration of vancomycin additionally increased by 71.77% and 73.62% in 10% 100 mW/cm2 ultrasound group and 300 mW/cm2 group respectively comparing with 10% control group; while increased 13.03% and 23.78% in 5% 100 mW/cm2 and 300 mW/cm2 groups comparing with 5% control group. Furthermore, the total release was positively correlated with the ultrasound intensity (P 0.05) and the amount of vancomycin loaded in specimens (P 0.01). The total release of vancomycin increased by 148.18% (P 0.01) and 82.39% (P 0.05) in 7.5% specimens during a 1 d period and a 5 d period in vivo, respectively, caused by intermittent 30 min exposures of ultrasound with an intensity of 300 mW/cm2. More decreased residue of vancomycin was detected in the ultrasound group than in the control group four weeks after implantations (P 0.01). Conclusion Low-frequency low-intensity continuous ultrasound may provide an effective method to enhance and accelerate the vancomycin release of ALBC.

In Vitro Release of Lyophilized Aclacinomycin A Solid Lipid Nanoparticle

Surfactant Mediated Accelerated and Discriminatory In Vitro Drug Release Method for PLGA Nanoparticles of Poorly Water-Soluble Drug

Preparation, Characterization And In Vitro Release Properties Of Ibuprofen-Loaded Microspheres Based On Polylactide, Poly(Epsilon-Caprolactone) And Their Copolymers

Preparation, characterization and in vitro release properties of ibuprofen-loaded microspheres based on polylactide, poly(ε-caprolactone) and their copolymers

RGD-modified Liposomes Enhance Efficiency of Aclacinomycin A Delivery: Evaluation of Their Effect in Lung Cancer.

The Effect Acetic Acid Has on Poly(N-Vinylcaprolactam) LCST for Biomedical Applications

Optimization, characterization and in vitro/vivo evaluation of azilsartan nanocrystals

CONTROLLED RELEASE OF SALICYLIC ACID FROM ELECTROSPUN MATS OF POLY(Ε-CAPROLACTONE) WITH LOW CRYSTALLINITY

Effect of Ultrasound on Drug Release of Vancomycin-Loaded Acrylic Bone Cement

Studies on in Vitro Release of Cyclosporine A-loaded Microspheres

Accelerated Release of Simvastatin Polylactic Acid Microspheres in Vitro

MODULATING THE DRUG SOLUBILITY OF ACECLOFENAC BY DESIGN AS SOLID LIPID PARTICLES: IN VITRO/IN VIVO CORRELATION

Accelerated in vitro release testing using USP apparatus 2 to predict rat in vivo performance of single agent and combination long-acting injectable suspension products

Preparation and in Vitro Release Kinetics of Amphotericin B-Loaded Poly(Ethyleneglycol)-Poly(dl-Lac-tide)Block Copolymer Micelles

Preparation, Characterization, and Drug Release Behaviors of Drug-Loaded E-Caprolactone/l-lactide Copolymer Nanoparticles

Freeze-drying and in vitro release kinetics of poly(ethylene glycol)Poly(dl-lactide) block copolymer micelles

Release in Vitro and Swelling of 5-Fluorouracil-loaded Chitosan Microspheres for Intranasal Administration

Supercritical Assisted Atomization for Preparation of Solid Lipid Nanoparticles

Preparation, Characterization, and Drug Release in Vitro of Chitosan-Glycyrrhetic Acid Nanoparticles.

Preparation of Insulin-Loaded PLA/PLGA Microcapsules by a Novel Membrane Emulsification Method and Its Release in Vitro.

An NMR Protocol for In Vitro Paclitaxel Release from an Albumin-Bound Nanoparticle Formulation